Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Brendan Doyle currently holds 627,509 shares of COGNITION THERAPEUTICS INC (CGTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Brendan Doyle has been a net buyer of CGTX stock. They have purchased $11.3K and sold $0 worth of shares.
John Brendan Doyle's most recent insider trade was on Apr 16, 2026, when they purchased 10,000 shares at $1.13 per share.
John Brendan Doyle serves as Executive at COGNITION THERAPEUTICS INC (CGTX). They have executed 9 insider transactions totaling $11.3K over their tenure at the company.
John Brendan Doyle holds the position of Executive at COGNITION THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
John Brendan Doyle has shown a buying trading pattern, with $11.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John Brendan Doyle was on May 1, 2024, when they sold $17.0K worth of CGTX shares. This transaction involved 8,699 shares at $1.95 per share.
John Brendan Doyle currently owns 627,509 shares of COGNITION THERAPEUTICS INC (CGTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Brendan Doyle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Brendan Doyle has 9 Form 4 filings on record as an insider at COGNITION THERAPEUTICS INC.
Set alerts for John Brendan Doyle and 40,000+ other insiders.